Carl Zeiss Meditec AG (OTCMKTS:CZMWY – Get Free Report) was the target of a significant drop in short interest during the month of May. As of May 29th, there was short interest totaling 2,772 shares, a drop of 67.1% from the May 14th total of 8,438 shares. Based on an average daily trading volume, of 7,331 shares, the short-interest ratio is currently 0.4 days.
Wall Street Analyst Weigh In
Separately, Zacks Research cut shares of Carl Zeiss Meditec from a “hold” rating to a “strong sell” rating in a report on Monday, May 25th. One research analyst has rated the stock with a Buy rating, three have issued a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, the company has a consensus rating of “Hold”.
Get Our Latest Stock Analysis on CZMWY
Carl Zeiss Meditec Trading Down 1.4%
About Carl Zeiss Meditec
Carl Zeiss Meditec AG is a global medical technology company headquartered in Jena, Germany. Founded in 2002 as a spin-off from the Carl Zeiss Group, the business leverages the parent company’s expertise in optics and precision engineering. Over the years, Carl Zeiss Meditec has grown through organic development and strategic acquisitions, becoming a recognized provider of innovative surgical and diagnostic solutions for eye care and microsurgery.
The company’s core offerings span two primary divisions: Ophthalmic Devices and Microsurgery.
Recommended Stories
- Five stocks we like better than Carl Zeiss Meditec
- Everpure: AI Storage Uncertainty Overshadows Breakneck Growth
- This Tech ETF Is Beating QQQ—and Canada May Be Part of the Reason
- Intel Is the Market’s Most Mispriced AI Hedge
- The Biggest Opportunity From SpaceX’s IPO May Surprise You
Receive News & Ratings for Carl Zeiss Meditec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Carl Zeiss Meditec and related companies with MarketBeat.com's FREE daily email newsletter.
